Table 5.

Multivariate analyses of the likelihood of improved CRISS with treatment before and after IPTW after recoding patient global assessment scores

	Before IPTW		After IPTW
	OR (95% CI)	p values	OR (95% CI)	p values
Immunosuppression use	2.08 (0.78, 5.57)	0.14	1.86 (1.07, 3.24)	0.03
Female	0.89 (0.32, 2.47)	0.83	1.25 (0.58, 2.63)	0.56
Age	1.00 (0.97, 1.04)	0.84	1.03 (1.00, 1.06)	0.04
Disease duration	1.02 (0.97, 1.06)	0.47	1.01 (0.98, 1.03)	0.57

IPTW inverse probability of treatment weighting, OR (95% CI) odds ratio with 95% confidence interval